Marker: D15Rat1 |
Symbol: |
D15Rat1 |
Previously known as: |
R0037-B11; oxsts6245; R037-B11;
|
RGD ID: |
36516 |
Expected Size: |
280 (bp) |
Position |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 15 | 7,411,915 - 7,412,193 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 15 | 8,097,058 - 8,097,335 | NCBI | Rnor6.0 | Rnor_5.0 | 15 | 12,160,114 - 12,160,391 | UniSTS | Rnor5.0 | RGSC_v3.4 | 15 | 8,988,164 - 8,988,442 | RGD | RGSC3.4 | RGSC_v3.4 | 15 | 8,988,165 - 8,988,442 | UniSTS | RGSC3.4 | RGSC_v3.1 | 15 | 8,988,165 - 8,988,442 | RGD | | Celera | 15 | 7,467,562 - 7,467,839 | UniSTS | | RH 3.4 Map | 15 | 72.4 | RGD | | RH 3.4 Map | 15 | 72.4 | UniSTS | | RH 2.0 Map | 15 | 49.8 | RGD | | SHRSP x BN Map | 15 | 1.6299 | RGD | | Cytogenetic Map | 15 | p16 | UniSTS | |
|
Is Marker For: |
Strains:
AVN/Orl
BBDP/Rhw
BBDR/Rhw
BC/CpbU
BDIX/Han
BDVII/Cub
BN/SsNHsd
BP/Cub
BUF/Pit
DA/PitN
DON/Melb
F344/Pit
FHH/Eur
IS/Kyo
LE/Mol
LEW/Pit
LH/Mav
MHS/Gib
MNRA/N
WN/N
WKY/OlaHsd
WTC/Kyo
LOU/CHan
MNR/N
MR/Pit
ODU/N
WF/Pit
WIST/Nhg
SR/Jr
MNS/Gib
OKA/Wsl
OM/Ztm
P5C
PVG/Pit
SD/Rij
SHR/OlaHsd
SHRSP/Riv
GK/KyoSwe
M520/N
BN-Lx/Cub
LN/Mav
GH/Omr
NEDH/K
SS/Jr
COP/OlaHsd
QTLs:
Despr13
Genes:
LOC680961
|
QTLs in Region (mRatBN7.2)
1354657 | Despr13 | Despair related QTL 13 | | 0.0022 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 15 | 1 | 29912054 | Rat |
8552920 | Pigfal8 | Plasma insulin-like growth factor 1 level QTL 8 | 3 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 15 | 1 | 34723002 | Rat |
8694361 | Abfw6 | Abdominal fat weight QTL 6 | 10.2 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 15 | 1 | 34723002 | Rat |
9589149 | Insul29 | Insulin level QTL 29 | 9.06 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 15 | 1 | 34723002 | Rat |
731170 | Pur3 | Proteinuria QTL 3 | 2.3 | 0.0005 | urine protein amount (VT:0005160) | urine protein excretion rate (CMO:0000759) | 15 | 1 | 41686771 | Rat |
1641887 | Alcrsp14 | Alcohol response QTL 14 | | | response to alcohol trait (VT:0010489) | brain neurotensin receptor 1 density (CMO:0002068) | 15 | 1 | 42356671 | Rat |
2298549 | Neuinf12 | Neuroinflammation QTL 12 | 3.5 | | nervous system integrity trait (VT:0010566) | spinal cord beta-2 microglobulin mRNA level (CMO:0002125) | 15 | 1 | 55302115 | Rat |
10401805 | Kidm51 | Kidney mass QTL 51 | | | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 15 | 306329 | 45306329 | Rat |
5684946 | Bss98 | Bone structure and strength QTL 98 | 3.9 | 0.0026 | tibia strength trait (VT:1000284) | tibia ultimate force (CMO:0001734) | 15 | 1058250 | 14481294 | Rat |
1641913 | Colcr2 | Colorectal carcinoma resistance QTL 2 | 6.57 | 0.0197 | intestine integrity trait (VT:0010554) | colorectal tumor number (CMO:0001794) | 15 | 2266368 | 22711984 | Rat |
1641913 | Colcr2 | Colorectal carcinoma resistance QTL 2 | 6.57 | 0.0197 | intestine integrity trait (VT:0010554) | poorly differentiated malignant colorectal tumor number (CMO:0002076) | 15 | 2266368 | 22711984 | Rat |
738017 | Hcas7 | Hepatocarcinoma susceptibility QTL 7 | 2.91 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 15 | 2266368 | 46921453 | Rat |
1582251 | Gluco24 | Glucose level QTL 24 | 3.2 | 0.0008 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 15 | 5530756 | 50530756 | Rat |